SCHEMBL7557798

SCHEMBL7557798

Cc1cc(C(=O)O)ccc1N(C(=O)CNC(=O)OCc1ccccc1)C1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
OPRK1 P41145 1/20 0.43
LMNA P02545 3/20 0.42
HTT P42858 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TBXA2R P21731 1/20 0.41
ENPP2 Q13822 1/20 0.41
PREP P48147 2/20 0.41
OPRD1 P41143 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
KDM1A O60341 1/20 0.39
RCOR1 Q9UKL0 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7558858 0.82 ENPP2 (0.40) CTSLCTSBCTSSCTSKLMNA
SCHEMBL6554460 0.80 CTSL (0.39) ALDH1A1CTSLCTSBCTSSCTSK
SCHEMBL7560287 0.77 MAPT (0.43) ALDH1A1LMNAKMT2AENPP2L3MBTL1
SCHEMBL6554480 0.75 SMN1; SMN2 (0.41) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL31555388 0.74 ALDH1A1 (0.61) ALDH1A1CTSLCTSBCTSSCTSK
SCHEMBL5096741 0.73 LMNA (0.62) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL5111276 0.71 LMNA (0.60) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL6554915 0.70 CTSB (0.45) ALDH1A1CTSLCTSBCTSSCTSK
SCHEMBL7167123 0.70 ALDH1A1 (0.47) ALDH1A1LMNAHTTMEN1KMT2A
SCHEMBL4027153 0.69 CTSL (0.51) ALDH1A1CTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151534-A1 Antithrombotic compounds BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151534-A1 Antithrombotic compounds SERPINC1, PF4, F2 ALDH1A1 192/4885CTSL 2137/4885CTSB 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.